Literature DB >> 6988039

Protective effect of inhaled salbutamol powder in children assessed by histamine challenge.

C R Pullan, A J Martin.   

Abstract

A double-blind placebo-controlled trial of 100, 400, and 800 micrograms inhaled salbutamol powder was conducted on 12 children. The protective effect at 10 minutes, two hours, and four hours was assessed by histamine challenge. At 10 minutes there was good protection with all doses, but by four hours there was significant protection only with 800 micrograms (p less than 0.01). Salbutamol powder may need to be taken at least every four hours for complete protection. There was a dose-related effect with a single dose of up to 800 micrograms; increasing the dose increased the effect and duration of action. Currently advertised dose regimens of salbutamol powder for children (200 micrograms three or four times a day) are apparently submaximal. Histamine challenge is a satisfactory method of assessing the proective effect of a drug in asthmatic children.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988039      PMCID: PMC1600893          DOI: 10.1136/bmj.280.6211.364

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Standardization of bronchial inhalation challenge procedures.

Authors:  H Chai; R S Farr; L A Froehlich; D A Mathison; J A McLean; R R Rosenthal; A L Sheffer; S L Spector; R G Townley
Journal:  J Allergy Clin Immunol       Date:  1975-10       Impact factor: 10.793

2.  Lung function in childhood. I. The forced expiratory volumes in healthy children using a spirometer and reverse plethysmograph.

Authors:  J J Cogswell; D Hull; A D Milner; A P Norman; B Taylor
Journal:  Br J Dis Chest       Date:  1975-01

3.  Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients.

Authors:  J T GOEI; H BOOY-NOORD; N G ORIE
Journal:  Int Arch Allergy Appl Immunol       Date:  1962

4.  Protective effect of drugs on histamine-induced asthma.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Thorax       Date:  1977-08       Impact factor: 9.139

5.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

6.  Evaluation of the effects of isoprenaline and salbutamol aerosols on airways obstruction and pulse rates of children with asthma.

Authors:  G Hambleton; E A Shinebourne
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

7.  Bronchial hypersensitivity to mecholyl and histamine in asthma subjects.

Authors:  I H Itkin
Journal:  J Allergy       Date:  1967-10

8.  Use of salbutamol powder in childhood asthma.

Authors:  W Lenney; A D Milner; E J Hiller
Journal:  Arch Dis Child       Date:  1978-12       Impact factor: 3.791

9.  Bronchial reactivity in cystic fibrosis.

Authors:  C M Mellis; H Levison
Journal:  Pediatrics       Date:  1978-03       Impact factor: 7.124

10.  Comparison of salbutamol Rotahaler with conventional pressurized aerosol.

Authors:  M R Hetzel; T J Clark
Journal:  Clin Allergy       Date:  1977-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.